SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jianxia Tang, Jimin Xiong, Tingting Wu, Zhangui Tang, Gang Ding, Chunmei Zhang, Songlin Wang, Yi Liu, Aspirin Treatment Improved Mesenchymal Stem Cell Immunomodulatory Properties via the 15d-PGJ2/PPARγ/TGF-β1 Pathway, Stem Cells and Development, 2014, 23, 17, 2093

    CrossRef

  2. 2
    Giuseppe Vassalli, Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation, Journal of Transplantation, 2013, 2013, 1

    CrossRef

  3. 3
    Muzammal Hussain, Aqeel Javeed, Muhammad Ashraf, Yong Zhao, Muhammad Mahmood Mukhtar, Muti Ur Rehman, Aspirin and immune system, International Immunopharmacology, 2012, 12, 1, 10

    CrossRef

  4. 4
    Sharla M. Peters, Haile Yancy, Christine Deaver, Yolanda L. Jones, Elizabeth Kenyon, Oscar A. Chiesa, Juan Esparza, Rudell Screven, Vicki Lancaster, John T. Stubbs, Maocheng Yang, Paddy L. Wiesenfeld, Michael J. Myers, In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration, Veterinary Immunology and Immunopathology, 2012, 148, 3-4, 236

    CrossRef

  5. 5
    Kher Hsin Chiow, Yingrou Tan, Rong Yuan Chua, Dachuan Huang, Mah Lee Mary Ng, Federico Torta, Markus R. Wenk, Siew Heng Wong, SNX3-dependent regulation of epidermal growth factor receptor (EGFR) trafficking and degradation by aspirin in epidermoid carcinoma (A-431) cells, Cellular and Molecular Life Sciences, 2012, 69, 9, 1505

    CrossRef

  6. 6
    Deyu Tarika Cai, Yong Hou Sunny Ho, Kher Hsin Chiow, Seok Hui Wee, Yulan Han, Meng Teng Peh, Siew Heng Wong, Aspirin regulates SNARE protein expression and phagocytosis in dendritic cells, Molecular Membrane Biology, 2011, 28, 2, 90

    CrossRef

  7. 7
    Brett Phillips, Massimo Trucco, Nick Giannoukakis, Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?, Clinical and Developmental Immunology, 2011, 2011, 1

    CrossRef

  8. 8
    Emily A. Van Vré, Ilse Van Brussel, Johan M. Bosmans, Christiaan J. Vrints, Hidde Bult, Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques, Mediators of Inflammation, 2011, 2011, 1

    CrossRef

  9. 9
    Annelinde Terlou, Alex Kleinjan, Ilse Beckmann, Claudia Heijmans-Antonissen, Manon van Seters, Lindy A.M. Santegoets, Marc van Beurden, Theo J.M. Helmerhorst, Leen J. Blok, Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia, International Journal of Cancer, 2011, 128, 10
  10. 10
    Shirley L. MacDonald, Ian Downing, Anne P.M. Atkinson, Ronald C.J. Gallagher, Marc L. Turner, David C. Kilpatrick, Dendritic cells previously exposed to mannan-binding lectin enhance cytokine production in allogeneic mononuclear cell cultures, Human Immunology, 2010, 71, 11, 1077

    CrossRef

  11. 11
    Mark F. McCarty, Jorge Barroso-Aranda, Francisco Contreras, Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy, Medical Hypotheses, 2010, 74, 5, 789

    CrossRef

  12. 12
    Biljana Bufan, Slavko Mojsilović, Dragana Vučićević, Dragana Vučević, Saša Vasilijić, Bela Balint, Miodrag Čolić, Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro, International Immunopharmacology, 2009, 9, 7-8, 910

    CrossRef

  13. 13
    Luciano Adorini, Giuseppe Penna, Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists, Human Immunology, 2009, 70, 5, 345

    CrossRef

  14. 14
    Brett Phillips, Nick Giannoukakis, Massimo Trucco, Dendritic cell-based therapy in Type 1 diabetes mellitus, Expert Review of Clinical Immunology, 2009, 5, 3, 325

    CrossRef

  15. 15
    Rachel Wai-Sum Li, Sai-Wang Seto, Alice Lai-Shan Au, Yiu-Wa Kwan, Shun-Wan Chan, Simon Ming-Yuen Lee, Chung-Ming Tse, George Pak-Heng Leung, Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells, European Journal of Pharmacology, 2009, 612, 1-3, 15

    CrossRef

  16. 16
    Maria Grazia Rimoli, Emilio Russo, Mauro Cataldi, Rita Citraro, Paolo Ambrosino, Daniela Melisi, Annalisa Curcio, Salvatore De Lucia, Paola Patrignani, Giovambattista De Sarro, Enrico Abignente, T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin, Neuropharmacology, 2009, 56, 3, 637

    CrossRef

  17. 17
    Aqeel Javeed, Baojun Zhang, Yanyan Qu, Aijun Zhang, Chenming Sun, Lianjun Zhang, Jun Liu, Chun Zeng, Yong Zhao, The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice, Transplant Immunology, 2009, 20, 4, 253

    CrossRef

  18. 18
    Sriram Chitta, Laura Santambrogio, Lawrence J. Stern, GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells, Immunology Letters, 2008, 116, 1, 41

    CrossRef

  19. 19
    Urban Švajger, Alenka Vidmar, Matjaž Jeras, Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4, International Immunopharmacology, 2008, 8, 7, 997

    CrossRef

  20. 20
    K. Atarashi, K. Kabashima, K. Akiyama, Y. Tokura, Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice, British Journal of Dermatology, 2008, 159, 2
  21. 21
    Elvira Bailón, Mònica Comalada, Juan Román, Pedro Michelena, Isabel Ramis, Manuel Merlos, Ana Nieto, Angel Concha, Antonio Zarzuelo, Julio Gálvez, UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis, Inflammatory Bowel Diseases, 2008, 14, 7
  22. 22
    Zorica Stojić Vukanić, Miodrag Čolić, M. Dimitrijević, Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro, International Immunopharmacology, 2007, 7, 2, 167

    CrossRef

  23. 23
    Massimo Trucco, Nick Giannoukakis, Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus, Expert Opinion on Biological Therapy, 2007, 7, 7, 951

    CrossRef

  24. 24
    Ana Hernandez, Melissa Burger, Bonnie B. Blomberg, William A. Ross, Jeffrey J. Gaynor, Inna Lindner, Robert Cirocco, James M. Mathew, Manuel Carreno, Yidi Jin, Kelvin P. Lee, Violet Esquenazi, Joshua Miller, Inhibition of NF-κB during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches, Human Immunology, 2007, 68, 9, 715

    CrossRef

  25. 25
    Elvira Bailón, Desirée Camuesco, Ana Nieto, Angel Concha, Alberto Fernández de Arriba, Juan Román, Isabel Ramis, Manuel Merlos, Antonio Zarzuelo, Julio Gálvez, Mònica Comalada, The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition, Biochemical Pharmacology, 2007, 74, 10, 1496

    CrossRef

  26. 26
    Matthew Buckland, Charlotte Jago, Henrieta Fazekesova, Andrew George, Robert Lechler, Giovanna Lombardi, Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells, International Immunopharmacology, 2006, 6, 13-14, 1895

    CrossRef

  27. 27
    M. Buckland, C. B. Jago, H. Fazekasova, K. Scott, P. H. Tan, A. J. T. George, R. Lechler, G. Lombardi, Aspirin-Treated Human DCs Up-Regulate ILT-3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells, American Journal of Transplantation, 2006, 6, 9
  28. 28
    Mahyar Nouri-Shirazi, Angus W Thomson, Dendritic cells as promoters of transplant tolerance, Expert Opinion on Biological Therapy, 2006, 6, 4, 325

    CrossRef

  29. 29
    Holger Hackstein, Modulation of Dendritic Cells for Tolerance Induction*, Transfusion Medicine and Hemotherapy, 2006, 33, 2, 150

    CrossRef

  30. 30
    W. Bäumer, S. Krekeler, V. C. DeVries, F. Niedorf, T. Tschernig, M. Kietzmann, Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis, Experimental Dermatology, 2006, 15, 4
  31. 31
    H Hackstein, R Shapiro, A W. Thomson, Aspirin Promotes Kidney Allograft Survival and Function, Transplantation, 2005, 79, 2, 253

    CrossRef

  32. 32
    M.A. Michelin, J.S. Silva, F.Q.C. Cunha, Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection, Experimental Parasitology, 2005, 111, 2, 71

    CrossRef

  33. 33
    Rae S.M Yeung, Pathogenesis and treatment of Kawasaki??s disease, Current Opinion in Rheumatology, 2005, 17, 5, 617

    CrossRef

  34. 34
    Cees van Kooten, Andrea M Woltman, Dendritic cells as a target of immunosuppressive drugs, Transplantation Reviews, 2004, 18, 2, 70

    CrossRef

  35. 35
    Jan M. Schwab, Hermann J. Schluesener, Richard Meyermann, Charles N. Serhan, COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics?, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2003, 69, 5, 339

    CrossRef

  36. 36
    David A. Tipton, Jon C. Flynn, Sidney H. Stein, Mustafa Kh. Dabbous, Cyclooxygenase-2 Inhibitors Decrease Interleukin-1β–Stimulated Prostaglandin E2and IL-6 Production by Human Gingival Fibroblasts, Journal of Periodontology, 2003, 74, 12, 1754

    CrossRef

  37. 37
    Adrian E. Morelli, Angus W. Thomson, Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction, Immunological Reviews, 2003, 196, 1
  38. 38
    Szczepan Józefowski, Małgorzata Bobek, Janusz Marcinkiewicz, Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved, International Immunopharmacology, 2003, 3, 6, 865

    CrossRef

  39. 39
    Masanori Abe, Angus W. Thomson, Influence of immunosuppressive drugs on dendritic cells, Transplant Immunology, 2003, 11, 3-4, 357

    CrossRef

  40. 40
    Basilia Zingarelli, Maeve Sheehan, Hector R. Wong, Nuclear factor-κB as a therapeutic target in critical care medicine, Critical Care Medicine, 2003, 31, Supplement, S105

    CrossRef

  41. 41
    Bianca Rocca, Garret A FitzGerald, Cyclooxygenases and prostaglandins: shaping up the immune response, International Immunopharmacology, 2002, 2, 5, 603

    CrossRef

  42. 42
    H. Harizi, N. Gualde, Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2002, 66, 5-6, 459

    CrossRef

  43. 43
    H. Harizi, M. Juzan, C. Grosset, M. Rashedi, N. Gualde, Dendritic Cells Issued in Vitro from Bone Marrow Produce PGE2 That Contributes to the Immunomodulation Induced by Antigen-Presenting Cells, Cellular Immunology, 2001, 209, 1, 19

    CrossRef

  44. 44
    Adrian E Morelli, Holger Hackstein, Angus W Thomson, Potential of tolerogenic dendritic cells for transplantation, Seminars in Immunology, 2001, 13, 5, 323

    CrossRef